Infectious Diseases – News and Features

An article published in Clinical and Developmental Immunology details how researchers have investigated humoral and cellular immune responses to M. tuberculosis-specific Ag85A, Ag85B, and ESAT-6 antigens in Brazilian patients with pulmonary or extrapulmonary tuberculosis, patients undergoing chemotherapy and noninfected healthy individuals.

The tests are designed utilizing IMDx's proprietary bioinformatics process which ensures high performing products that are optimized and in silico verified.

The data will be presented at the 40th Critical Care Congress of the Society of Critical Care Medicine, in San Diego, California.

It is known that teeth can protect themselves, to some extent, from attack by bacteria but that inflammation within a tooth can be damaging and, in extreme cases, lead to abscess or death of the tooth.

After using DecisionSite for six years, Biogemma selects the latest version of TIBCO Spotfire to improve the quality of its genomics analyses.

MGAH22 is an Fc-optimized monoclonal antibody developed by MacroGenics to reduce tumor growth significantly in a broad panel of HER2-expressing tumors.

Scientists have made an unanticipated discovery in mice that interferon-gamma, a type of protein primarily used by the immune system for intercellular communication, acts as a promoter for the deadly form of skin cancer known as melanoma.

AiCuris have announced that Dr. Marie-Paule Richard has assumed the responsibility of Chief Medical Officer at AiCuris, Germany.

Researchers from the International Citrus Genomics Consortium announced this weekend at the Plant and Animal Genome (PAG) XIX conference in San Diego, California the availability of the sequence assembly and annotation of the first citrus genomes, the sweet orange (Citrus sinensis) and the Clementine mandarin (Citrus clementina).

Researchers from the Universities of Dundee and Oxford have made a significant breakthrough in understanding how resistance to antibiotics might be overcome, by producing the first ever 3D molecular image of a key drug target and showing how drugs bind to it.